Trials / Active Not Recruiting
Active Not RecruitingNCT05358938
Exercise to Boost Response to Checkpoint Blockade Immunotherapy
- Status
- Active Not Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
30 minutes of moderate exercise on an arm ergometer, a cycle ergometer, or a treadmill prior to each administration of standard of care checkpoint blockade immunotherapy across all cycles
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Exercise | 30 minutes of moderate exercise on an arm ergometer, a cycle ergometer, or a treadmill prior to each administration of standard of care checkpoint blockade immunotherapy across all cycles |
| DRUG | Checkpoint Blockade, Immune | Participants will receive clinical care following Moffitt standards for the patient's disease type and therapeutic setting. |
Timeline
- Start date
- 2022-06-21
- Primary completion
- 2024-10-06
- Completion
- 2026-08-01
- First posted
- 2022-05-03
- Last updated
- 2026-02-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05358938. Inclusion in this directory is not an endorsement.